Franklin M Berger sold $1.0M of AVIR
director at Atea Pharmaceuticals, Inc.. 359,606 shares at an average of $2.85, traded Dec 10, 2024, filed Dec 12, 2024.
Score components
- +15RoleDirector
- +25Trade size$1.0M at market
- +10Share of holdings soldSold 44% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.8%, 3m +3.7%, 6m +8.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-135930, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2024 | SOpen-market sale Common Stock | -359,606 | $2.85 | $1.0M | 451,897 | Dec 12, 2024 |
Related signals
Other insiders at Atea Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | AVIRbuy Atea Pharmaceuticals, Inc. | Franklin M Berger director | $81k 25,000 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.